• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  modified a-cobratoxin
Date Designated:  09/01/2015
Orphan Designation:  Treatment of pediatric multiple sclerosis (0 through 16 years of age).
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Nutra Pharma Corporation
12502 W. Atlantic Blvd
Coral Springs, Florida 33071
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.